Hepion Pharmaceuticals, Inc. Annual Return On Assets in % from 2014 to 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Hepion Pharmaceuticals, Inc. quarterly/annual Return On Assets history and growth rate from 2014 to 2024.
  • Hepion Pharmaceuticals, Inc. Return On Assets for the quarter ending December 31, 2024 was -193 %, a 27.4% decline year-over-year.
  • Hepion Pharmaceuticals, Inc. annual Return On Assets for 2024 was -193 %, a 27.4% decline from 2023.
  • Hepion Pharmaceuticals, Inc. annual Return On Assets for 2023 was -152 %, a 178% decline from 2022.
  • Hepion Pharmaceuticals, Inc. annual Return On Assets for 2022 was -54.6 %, a 91.2% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2024 -193 -41.5 -27.4% Jan 1, 2024 Dec 31, 2024
2023 -152 -97 -178% Jan 1, 2023 Dec 31, 2023
2022 -54.6 -26 -91.2% Jan 1, 2022 Dec 31, 2022
2021 -28.5 +41.4 +59.2% Jan 1, 2021 Dec 31, 2021
2020 -70 -31.4 -81.3% Jan 1, 2020 Dec 31, 2020
2019 -38.6 +56 +59.2% Jan 1, 2019 Dec 31, 2019
2018 -94.6 +13.6 +12.6% Jan 1, 2018 Dec 31, 2018
2017 -108 +95.6 +46.9% Jul 1, 2016 Jun 30, 2017
2016 -204 +27.2 +11.8% Jul 1, 2015 Jun 30, 2016
2015 -231 +216 +48.3% Jul 1, 2014 Jun 30, 2015
2014 -447 Jul 1, 2013 Jun 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.